Industry: Service & Software
Published Date: 2026-07-15
Pages: 105 Pages
Report ld: 6973609
Request Sample
Customized Report
The global market for Life Sciences Software was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Life science deals with the scientific study of organisms such as microorganism, human being, and animals. It includes broad range of areas of study such as biology, anatomy, health sciences, and medical sciences. The software used in life science allows a user to increase efficacy & reduce the cost of deploying valuable IT infrastructure. For instance, software as a service (SaaS) model for life science offers a pay per use model, which provides more feasibility to store patient data.
Rise in need for the improvement of operational efficiency and enhanced performance of the organization by collection & management of data efficiently by using life sciences software drive the growth of the global life sciences software market. However, high cost associated with the implementation of software impedes the market growth. Adoption of mergers and acquisitions (M&A) strategies among various life sciences companies is expected to offer a major opportunity for market expansion.
The North American market for Life Sciences Software was valued at US$ million in 2025 and is projected to reach US$ million by 2032, at a CAGR of % from 2026 to 2032.
The Asia-Pacific market for Life Sciences Software was valued at $ million in 2025 and is projected to climb to US$ million by 2032, at a CAGR of % from 2026 to 2032.
The European market for Life Sciences Software was valued at $ million in 2025 and is projected to total US$ million by 2032, at a CAGR of % from 2026 to 2032.
The global key companies in the Life Sciences Software market include QuintilesIMS Incorporated, Autodesk Inc, PAREXEL International Corporation, Model N, Dassault Systèmes, CSC, International Business Machines Corp, SAP SE, Veeva Systems, Medidata Solutions, Inc, etc. In 2025, the five largest players accounted for approximately % of revenue.
This report provides a comprehensive view of the global market for Life Sciences Software, covering total sales revenue, the market share and ranking of key companies, along with analyses by region & country, by Type, and by Application.
The Life Sciences Software market size, estimations, and forecasts are presented in terms of sales revenue ($ millions), with 2025 as the base year and historical and forecast data from 2021 to 2032. The report combines quantitative and qualitative analysis to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current marketplace, and make informed business decisions regarding Life Sciences Software.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Introduces the scope of the report and the global market size (value). It also summarizes market dynamics and recent developments; identifies key drivers and restraints; outlines challenges and risks for players; reviews relevant industry policies.
Chapter 2: Provides a detailed analysis of the Life Sciences Software companies' competitive landscape—including revenue shares, recent development plans, and mergers and acquisitions (M&A).
Chapter 3: Analyzes market segmentation by Type, presenting the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 4: Analyzes market segmentation by Application, presenting the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 5: Presents Life Sciences Software revenue at the regional level. It offers a quantitative assessment of market size and growth potential by region and summarizes market development, future prospects, addressable space, and country-level market size worldwide.
Chapter 6: Presents Life Sciences Software revenue at the country level. It provides segmented data by Type and by Application for each country/region.
Chapter 7: Profiles key players, detailing the main companies' product revenue, gross margin, product portfolios, recent developments, etc.
Chapter 8: Analysis of Value Chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 Life Sciences Software Product Introduction
1.2 Global Life Sciences Software Market Size Forecast (2021–2032)
1.3 Life Sciences Software Market Trends & Drivers
1.3.1 Life Sciences Software Industry Trends
1.3.2 Life Sciences Software Market Drivers & Opportunities
1.3.3 Life Sciences Software Market Challenges
1.3.4 Life Sciences Software Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Life Sciences Software Players Revenue Ranking (2025)
2.2 Global Life Sciences Software Revenue by Company (2021–2026)
2.3 Key Companies’ R&D and Operations Footprint and Headquarters
2.4 Key Companies Life Sciences Software Product Offerings
2.5 Key Companies General Availability (GA) Timeline for Life Sciences Software
2.6 Life Sciences Software Market Competitive Analysis
2.6.1 Life Sciences Software Market Concentration Rate (2021–2026)
2.6.2 Top 5 and Top 10 Global Companies by Life Sciences Software Revenue in 2025
2.6.3 Global Companies by Tier (Tier 1, Tier 2, Tier 3), based on Life Sciences Software revenue, 2025
2.7 Mergers & Acquisitions and Expansion
3 Segmentation Life Sciences Software Market Classification
3.1 Introduction by Type
3.1.1 Cloud-based
3.1.2 On-premises
3.1.3 Global Life Sciences Software Sales Value by Type
3.1.3.1 Global Life Sciences Software Sales Value by Type (2021 vs 2025 vs 2032)
3.1.3.2 Global Life Sciences Software Sales Value, by Type (2021–2032)
3.1.3.3 Global Life Sciences Software Sales Value, by Type (%), 2021–2032
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Pharmaceuticals
4.1.2 Biotechnology
4.1.3 Others
4.2 Global Life Sciences Software Sales Value by Application
4.2.1 Global Life Sciences Software Sales Value by Application (2021 vs 2025 vs 2032)
4.2.2 Global Life Sciences Software Sales Value by Application (2021–2032)
4.2.3 Global Life Sciences Software Sales Value by Application (%), 2021–2032
5 Segmentation by Region
5.1 Global Life Sciences Software Sales Value by Region
5.1.1 Global Life Sciences Software Sales Value by Region: 2021 vs 2025 vs 2032
5.1.2 Global Life Sciences Software Sales Value by Region (2021–2026)
5.1.3 Global Life Sciences Software Sales Value by Region (2027–2032)
5.1.4 Global Life Sciences Software Sales Value by Region (%), 2021–2032
5.2 North America
5.2.1 North America Life Sciences Software Sales Value, 2021–2032
5.2.2 North America Life Sciences Software Sales Value by Country (%), 2025 vs 2032
5.3 Europe
5.3.1 Europe Life Sciences Software Sales Value, 2021–2032
5.3.2 Europe Life Sciences Software Sales Value by Country (%), 2025 vs 2032
5.4 Asia Pacific
5.4.1 Asia Pacific Life Sciences Software Sales Value, 2021–2032
5.4.2 Asia Pacific Life Sciences Software Sales Value by Subregion (%), 2025 vs 2032
5.5 South America
5.5.1 South America Life Sciences Software Sales Value, 2021–2032
5.5.2 South America Life Sciences Software Sales Value by Country (%), 2025 vs 2032
5.6 Middle East & Africa
5.6.1 Middle East & Africa Life Sciences Software Sales Value, 2021–2032
5.6.2 Middle East & Africa Life Sciences Software Sales Value by Country (%), 2025 vs 2032
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Life Sciences Software Sales Value Growth Trends, 2021 vs 2025 vs 2032
6.2 Key Countries/Regions Life Sciences Software Sales Value, 2021–2032
6.3 United States
6.3.1 United States Life Sciences Software Sales Value, 2021–2032
6.3.2 United States Life Sciences Software Sales Value by Type (%), 2025 vs 2032
6.3.3 United States Life Sciences Software Sales Value by Application, 2025 vs 2032
6.4 Europe
6.4.1 Europe Life Sciences Software Sales Value, 2021–2032
6.4.2 Europe Life Sciences Software Sales Value by Type (%), 2025 vs 2032
6.4.3 Europe Life Sciences Software Sales Value by Application, 2025 vs 2032
6.5 China
6.5.1 China Life Sciences Software Sales Value, 2021–2032
6.5.2 China Life Sciences Software Sales Value by Type (%), 2025 vs 2032
6.5.3 China Life Sciences Software Sales Value by Application, 2025 vs 2032
6.6 Japan
6.6.1 Japan Life Sciences Software Sales Value, 2021–2032
6.6.2 Japan Life Sciences Software Sales Value by Type (%), 2025 vs 2032
6.6.3 Japan Life Sciences Software Sales Value by Application, 2025 vs 2032
6.7 South Korea
6.7.1 South Korea Life Sciences Software Sales Value, 2021–2032
6.7.2 South Korea Life Sciences Software Sales Value by Type (%), 2025 vs 2032
6.7.3 South Korea Life Sciences Software Sales Value by Application, 2025 vs 2032
6.8 Southeast Asia
6.8.1 Southeast Asia Life Sciences Software Sales Value, 2021–2032
6.8.2 Southeast Asia Life Sciences Software Sales Value by Type (%), 2025 vs 2032
6.8.3 Southeast Asia Life Sciences Software Sales Value by Application, 2025 vs 2032
6.9 India
6.9.1 India Life Sciences Software Sales Value, 2021–2032
6.9.2 India Life Sciences Software Sales Value by Type (%), 2025 vs 2032
6.9.3 India Life Sciences Software Sales Value by Application, 2025 vs 2032
7 Company Profiles
7.1 QuintilesIMS Incorporated
7.1.1 QuintilesIMS Incorporated Profile
7.1.2 QuintilesIMS Incorporated Main Business
7.1.3 QuintilesIMS Incorporated Life Sciences Software Products, Services, and Solutions
7.1.4 QuintilesIMS Incorporated Life Sciences Software Revenue (US$ Million), 2021–2026
7.1.5 QuintilesIMS Incorporated Recent Developments
7.2 Autodesk Inc
7.2.1 Autodesk Inc Profile
7.2.2 Autodesk Inc Main Business
7.2.3 Autodesk Inc Life Sciences Software Products, Services, and Solutions
7.2.4 Autodesk Inc Life Sciences Software Revenue (US$ Million), 2021–2026
7.2.5 Autodesk Inc Recent Developments
7.3 PAREXEL International Corporation
7.3.1 PAREXEL International Corporation Profile
7.3.2 PAREXEL International Corporation Main Business
7.3.3 PAREXEL International Corporation Life Sciences Software Products, Services, and Solutions
7.3.4 PAREXEL International Corporation Life Sciences Software Revenue (US$ Million), 2021–2026
7.3.5 PAREXEL International Corporation Recent Developments
7.4 Model N
7.4.1 Model N Profile
7.4.2 Model N Main Business
7.4.3 Model N Life Sciences Software Products, Services, and Solutions
7.4.4 Model N Life Sciences Software Revenue (US$ Million), 2021–2026
7.4.5 Model N Recent Developments
7.5 Dassault Systèmes
7.5.1 Dassault Systèmes Profile
7.5.2 Dassault Systèmes Main Business
7.5.3 Dassault Systèmes Life Sciences Software Products, Services, and Solutions
7.5.4 Dassault Systèmes Life Sciences Software Revenue (US$ Million), 2021–2026
7.5.5 Dassault Systèmes Recent Developments
7.6 CSC
7.6.1 CSC Profile
7.6.2 CSC Main Business
7.6.3 CSC Life Sciences Software Products, Services, and Solutions
7.6.4 CSC Life Sciences Software Revenue (US$ Million), 2021–2026
7.6.5 CSC Recent Developments
7.7 International Business Machines Corp
7.7.1 International Business Machines Corp Profile
7.7.2 International Business Machines Corp Main Business
7.7.3 International Business Machines Corp Life Sciences Software Products, Services, and Solutions
7.7.4 International Business Machines Corp Life Sciences Software Revenue (US$ Million), 2021–2026
7.7.5 International Business Machines Corp Recent Developments
7.8 SAP SE
7.8.1 SAP SE Profile
7.8.2 SAP SE Main Business
7.8.3 SAP SE Life Sciences Software Products, Services, and Solutions
7.8.4 SAP SE Life Sciences Software Revenue (US$ Million), 2021–2026
7.8.5 SAP SE Recent Developments
7.9 Veeva Systems
7.9.1 Veeva Systems Profile
7.9.2 Veeva Systems Main Business
7.9.3 Veeva Systems Life Sciences Software Products, Services, and Solutions
7.9.4 Veeva Systems Life Sciences Software Revenue (US$ Million), 2021–2026
7.9.5 Veeva Systems Recent Developments
7.10 Medidata Solutions, Inc
7.10.1 Medidata Solutions, Inc Profile
7.10.2 Medidata Solutions, Inc Main Business
7.10.3 Medidata Solutions, Inc Life Sciences Software Products, Services, and Solutions
7.10.4 Medidata Solutions, Inc Life Sciences Software Revenue (US$ Million), 2021–2026
7.10.5 Medidata Solutions, Inc Recent Developments
8 Industry Chain Analysis
8.1 Life Sciences Software Value Chain
8.2 Life Sciences Software Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Key Suppliers of Raw Materials
8.2.3 Cost Structure
8.3 Midstream Analysis
8.4 Downstream (Customer) Analysis
8.5 Sales Model and Sales Channelss
8.5.1 Life Sciences Software Sales Model
8.5.2 Sales Channels
8.5.3 Life Sciences Software Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Life Sciences Software market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-04-28
Pages: 106
USD 2900.00
(Single User License)
The global Life Sciences Software market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-09-06
Pages: 80
USD 4250.00
(Single User License)
The global market for Life Sciences Software was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-02-27
Pages: 73
USD 2900.00
(Single User License)
The global market for Life Sciences Software was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-27
Pages: 94
USD 3950.00
(Single User License)
Life science deals with the scientific study of organisms such as microorganism, human being, and animals. It includes broad range of areas of study such as biology, anatomy, health sciences, and medical sciences. The software used in life science allows a user to increase efficacy & reduce the cost of deploying valuable IT infrastructure. For instance, software as a service (SaaS) model for life science offers a pay per use model, which provides more feasibility to store patient data.
Published Date: 2024-04-15
Pages: 107
USD 4900.00
(Single User License)
Life science deals with the scientific study of organisms such as microorganism, human being, and animals. It includes broad range of areas of study such as biology, anatomy, health sciences, and medical sciences. The software used in life science allows a user to increase efficacy & reduce the cost of deploying valuable IT infrastructure. For instance, software as a service (SaaS) model for life science offers a pay per use model, which provides more feasibility to store patient data.
Published Date: 2024-01-24
Pages: 111
USD 3950.00
(Single User License)
Life science deals with the scientific study of organisms such as microorganism, human being, and animals. It includes broad range of areas of study such as biology, anatomy, health sciences, and medical sciences. The software used in life science allows a user to increase efficacy & reduce the cost of deploying valuable IT infrastructure. For instance, software as a service (SaaS) model for life science offers a pay per use model, which provides more feasibility to store patient data.
Published Date: 2024-01-16
Pages: 82
USD 2900.00
(Single User License)
The global Life Sciences Software market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-04-28
Pages: 106
The global Life Sciences Software market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-09-06
Pages: 80
The global market for Life Sciences Software was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-02-27
Pages: 73
The global market for Life Sciences Software was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-27
Pages: 94
Life science deals with the scientific study of organisms such as microorganism, human being, and animals. It includes broad range of areas of study such as biology, anatomy, health sciences, and medical sciences. The software used in life science allows a user to increase efficacy & reduce the cost of deploying valuable IT infrastructure. For instance, software as a service (SaaS) model for life science offers a pay per use model, which provides more feasibility to store patient data.
Published: 2024-04-15
Pages: 107
Life science deals with the scientific study of organisms such as microorganism, human being, and animals. It includes broad range of areas of study such as biology, anatomy, health sciences, and medical sciences. The software used in life science allows a user to increase efficacy & reduce the cost of deploying valuable IT infrastructure. For instance, software as a service (SaaS) model for life science offers a pay per use model, which provides more feasibility to store patient data.
Published: 2024-01-24
Pages: 111
Life science deals with the scientific study of organisms such as microorganism, human being, and animals. It includes broad range of areas of study such as biology, anatomy, health sciences, and medical sciences. The software used in life science allows a user to increase efficacy & reduce the cost of deploying valuable IT infrastructure. For instance, software as a service (SaaS) model for life science offers a pay per use model, which provides more feasibility to store patient data.
Published: 2024-01-16
Pages: 82
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now